(Q46236729)

English

Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database

scientific article published in May 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

0 references

Martha K Terris

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

author name string

Christopher R King

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Stephen J Freedland

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Christopher J Kane

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Christopher L Amling

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

William J Aronson

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Joseph C Presti

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

language of work or name

0 references

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

69

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

921-926

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.056

7 January 2021

Identifiers

10.1016/J.UROLOGY.2007.01.056

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/17482935

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46236729&oldid=2101759469"